FierceBiotech
FierceBiotech is a B2B digital media publication and events business covering the global biotechnology industry with daily news, analysis, podcasts, trackers, and conferences, serving biotech executives, pharma professionals, and business development leaders under owner Questex LLC.
- Company typePrivate
- Founded2000
- HeadquartersWashington, United States
- Headcount51–100
- GTM typeB2B
- OfferingDigital Commerce or Content
What FierceBiotech does
FierceBiotech is a B2B digital media publication and events business serving the global biotechnology industry. Founded in 2000 and headquartered in Washington, D.C., the brand is operated by Questex LLC alongside sister publications Fierce Pharma and Fierce Healthcare, collectively reaching millions of industry leaders across pharma, biotech, and healthcare. The core product is the FierceBiotech website, which publishes daily news, analysis, and special reports covering drug development, clinical trials, regulatory approvals, M&A, venture capital, manufacturing, marketing, patent litigation, and government investigations across biotech verticals including cell and gene therapy, medtech, diagnostics, and CROs.
The platform is supported by The Top Line podcast (distributed on Apple Podcasts, Spotify, Amazon, and iHeart Radio), the Podnosis healthcare podcast, recurring editorial trackers (Layoff Tracker, Fundraising Tracker), and an awards and events portfolio including Fierce Biotech Week in Boston, Fierce Biotech at London Life Sciences Week (launching November 17, 2026 at The Savoy), the Fierce 50 awards gala, Fierce Outsourcing Awards, and Fierce Life Sciences Innovation Awards. Email newsletters and sponsored webinars extend audience reach and provide additional monetization surfaces.
FierceBiotech monetizes primarily through advertising and sponsorship (display ads, sponsored content, newsletter sponsorships, and brand partnerships), events and conferences (ticket sales and sponsorships), and content and resources (webinar sponsorships, whitepapers, special reports, and premium content access). Pricing is not publicly disclosed; advertising rates, sponsorship packages, and event registration fees are quote-based and vary by placement, duration, and package level. The audience is horizontal across biotech executives and investors, pharma industry professionals, and business development leaders who use the publication to track deals, regulatory developments, partnership opportunities, and emerging technologies. The company has 51–100 employees, is privately held under Questex LLC, and does not disclose brand-level revenue.
FierceBiotech firmographics
Firmographics- Name
- FierceBiotech
- Legal name
- Questex LLC
- Website
- https://fiercebiotech.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- FierceBiotech is a B2B digital media publication and events business covering the global biotechnology industry with daily news, analysis, podcasts, trackers, and conferences, serving biotech executives, pharma professionals, and business development leaders under owner Questex LLC.
- Ownership category
- akta.pro rank
FierceBiotech industry classification
Industry- Product category
- Biotech Industry Media and Publishing
- NAICS
- Periodical Publishers (513120)
- SIC
- Services-Advertising Agencies (7311)
- akta.pro primary industry
- B2B / Industrial Market Research (MPAAALAA)
Keywords
Where FierceBiotech is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Markets served
FierceBiotech business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D, Others
Revenue model
- Advertising and Sponsorship: Revenue generated from display advertising, sponsored content, newsletter sponsorships, and brand partnerships across the FierceBiotech digital platform.
- Events and Conferences: Revenue from ticket sales and sponsorships for events including Fierce Biotech Week (Boston), London Life Sciences Week forum, and the Fierce 50 Awards Gala.
- Content and Resources: Revenue from webinar sponsorships, whitepaper promotions, and access to special reports and premium content.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
FierceBiotech product offering
Product offeringCore offering
FierceBiotech is a B2B digital media brand that publishes daily biotech industry news, articles, analysis, and special reports covering drug development, clinical trials, regulatory approvals, M&A, venture capital, and industry trends. It monetizes its audience primarily through advertising, sponsored content, paid newsletters, webinars, and industry events such as Fierce Biotech Week and awards galas.
Product overview
FierceBiotech is a comprehensive biotech industry news and media platform providing breaking news, analysis, and data on drugs and the companies that develop them. The offering consists of a core news website (Fierce Biotech News & Reports) covering drug development through the entire lifecycle — tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations, M&A deals, and more. Supporting products include The Top Line podcast (weekly industry analysis), Special Reports (in-depth industry analysis), Fierce 50 awards program, Fierce Outsourcing Awards, and event properties including Fierce Biotech Week (Boston) and Fierce Biotech at London Life Sciences Week. The platform also offers newsletters and resources for industry professionals.
Differentiator
Problem solved
Functional benefit
Brands
- Fierce 50: Annual ranking and awards program recognizing top companies and leaders in the life sciences industry
- Fierce Outsourcing Awards
- Fierce Life Sciences Innovation Awards
- The Top Line
- Podnosis
Products and services
- Fierce Biotech News & Reports Breaking news and analysis covering the biotech industry — including drug development, clinical trials, IPOs, M&A, and companies pushing biopharma forward. The product provides the latest news, analysis, and data on drugs and the companies that make them, for biotech executives and industry professionals.
- Fierce Biotech Newsletter Email newsletter delivering the latest biotech news, analysis, and insights directly to subscribers in their inbox.
- The Top Line Podcast Weekly podcast where journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and analyze the week's biggest business news — from mergers and marketing to drug R&D and device development.
- Special Reports In-depth special reports that take stock of the industry's products and finances, and shed new light on industry trends including Top 10 pharma R&D budgets, Biotech's top money raisers, clinical trial flops, and layoff trackers.
- Fierce Biotech Week Annual industry conference held in Boston bringing together senior leaders from across global biotech, pharma, and investment sectors for curated discussions, deal-making, and networking focused on scientific innovation and investment trends.
- Fierce Biotech at London Life Sciences Week Inaugural one-day forum at The Savoy hotel in London coinciding with London Life Sciences Week, bringing together senior leaders from across global biotech, pharma, and investment sectors for curated discussions, deal-making, and networking.
- Fierce 50 Awards Program Annual recognition program honoring top companies and leaders in the life sciences sector, featuring a special report and awards gala.
- Fierce Outsourcing Awards Awards program recognizing excellence in outsourcing within the biotech and life sciences industry.
Companies that use FierceBiotech
Customer profileSegments3 records
Ideal customer profiles3 records
FierceBiotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
FierceBiotech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Questex LLCcoreFierceBiotech is owned and operated by Questex LLC, a life sciences media company. Questex provides corporate ownership, operational infrastructure, and portfolio synergy across Fierce Pharma, Fierce Biotech, and Fierce Healthcare brands, collectively reaching millions of industry leaders.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
FierceBiotech competitors and assessment
Company assessmentDirect peers
- Fierce Pharma: Fierce Pharma is the sister publication of FierceBiotech under Questex LLC, covering pharmaceutical industry news — the closest peer by business model, audience, and product mix, sharing events and editorial infrastructure.
- STAT News: STAT News is a Boston-based life sciences news outlet owned by Boston Globe Media that competes directly with FierceBiotech for biotech executive readership, with deeper resources and a broader healthcare scope.
- MedCity News: MedCity News covers healthcare innovation, biotech, and digital health with news, events, and sponsored content — a direct editorial and business-model peer to FierceBiotech, though with a broader healthcare remit.
- Pink Sheet (Citeline): The Pink Sheet is a long-running pharma and biotech industry news and analysis title under Citeline/Informa, directly comparable to FierceBiotech's regulatory and policy coverage with a paid subscription model.
- BioPharma Dive: BioPharma Dive is a B2B trade publication under Industry Dive covering biotech and pharma news, analysis, and special reports — closely overlapping FierceBiotech's editorial product and advertising-supported business model.
- Genetic Engineering & Biotechnology News (GEN): GEN is a B2B biotech trade publication covering drug discovery, bioprocessing, and biotech business news — a direct editorial peer with comparable advertising and event monetization.
- BioCentury: BioCentury is a long-established biotech intelligence publisher with news, analysis, and the BCIQ data platform — competing with FierceBiotech on editorial coverage and increasingly on premium intelligence products.
- Drug Discovery & Development: Drug Discovery & Development is a B2B trade publication covering biotech R&D, drug discovery technologies, and industry trends — a focused editorial peer with overlapping advertising-supported content monetization.
- Endpoints News: Endpoints News is a venture-backed daily biotech news publication directly competing with FierceBiotech for the same biotech executive and investor audience, with overlapping coverage of clinical data, M&A, and deal-making.
Broad incumbents
- Citeline / Pharma Intelligence (Informa): Citeline is Informa's pharma and biotech intelligence arm combining news, data, and analytics products — a broad incumbent with significant overlap to FierceBiotech's editorial coverage plus proprietary data assets FierceBiotech lacks.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
FierceBiotech social profiles
Digital presenceFierceBiotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
FierceBiotech leadership team
Management profileNumber of profiles
Profiles5 records
FierceBiotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FierceBiotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FierceBiotech
What does FierceBiotech do?
FierceBiotech is a B2B digital media brand that publishes daily biotech industry news, articles, analysis, and special reports covering drug development, clinical trials, regulatory approvals, M&A, venture capital, and industry trends. It monetizes its audience primarily through advertising, sponsored content, paid newsletters, webinars, and industry events such as Fierce Biotech Week and awards galas.
Is FierceBiotech a public or private company?
FierceBiotech is a private company. It is classified as corporate owned and is currently operating.
When was FierceBiotech founded?
FierceBiotech was founded in 2000. It employs 51 to 100 people.
Where is FierceBiotech based?
FierceBiotech is headquartered in Washington, United States, in the North America region.
How does FierceBiotech make money?
Three revenue lines are on record. Advertising and Sponsorship is the primary driver. The others are events and Conferences and content and Resources.
Who are FierceBiotech's main competitors?
Direct peers on record are Fierce Pharma, STAT News, MedCity News, Pink Sheet (Citeline), BioPharma Dive, Genetic Engineering & Biotechnology News (GEN), BioCentury, Drug Discovery & Development and Endpoints News. Citeline / Pharma Intelligence (Informa) is listed as a broad incumbent.
Does FierceBiotech have an API?
No public API is recorded for FierceBiotech.
What industry is FierceBiotech in?
FierceBiotech's product category is Biotech Industry Media and Publishing. Its primary akta.pro industry code is MPAAALAA, B2B / Industrial Market Research. Its NAICS code is 513120 and its SIC code is 7311.